Post marketing study of sivelestat sodium hydrate for acute lung injury associated with systemic inflammatory response syndrome
Phase 4
- Conditions
- Acute lung injury (ALI) associated with systemic inflammatory response syndrome (SIRS)
- Registration Number
- JPRN-jRCT1080220086
- Lead Sponsor
- ONO PHARMACEUTICAL CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Male and female patients with ALI associated with SIRS aged over 18 years old are included.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method